Erratum (DOI:10.1016/j.jpsychores.2008.06.002);Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women

Journal of Psychosomatic Research

Volumn 65, Issue 4, 2008, Pages 389-401

  Antoni, Michael H ^a,b,c   Pereira, Deidre B ^d   Marion, Ilona ^a   Ennis, Nicole ^a   Andrasik, Michele Peake ^a   Rose, Rachel ^a   McCalla, Judith ^a   Simon, Trudi ^b   Fletcher, Mary Ann ^a,b,c   Lucci, Joseph ^b,c   Efantis Potter, Jonell ^b   O'Sullivan, Mary Jo ^b  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cervical cancer; HIV; HPV; Stress; Stress management

Indexed keywords

ARTICLE; CANCER PREVENTION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIFE STRESS; PAPANICOLAOU TEST; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STRESS MANAGEMENT; SUBSTANCE ABUSE; UTERINE CERVIX TUMOR; VIRUS LOAD; WART VIRUS;

EID: 52049092073     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.09.007     Document Type: Erratum

References (36)

1. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
2. Bosch F.X., and de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr (2003) 3-13
3. Schmiedeskamp M.R., and Kockler D.R. Human papillomavirus vaccines. Ann Pharmacother 40 (2006) 1344-1352
4. Palefsky J.M., and Holly E.A. Chapter 6: immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr (2003) 41-46
5. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 23 (2000) 101-113
6. Man S. Human cellular immune responses against human papillomaviruses in cervical neoplasia. Expert Rev Mol Med 1998 (1998) 1-19
7. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P., Beral V., Berrington de González A., Colin D., Franceschi S., Goodill A., Green J., Petro J., Plummer M., and Sweetland S. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 118 (2006) 1481-1495
8. Pereira D.B., Antoni M.H., Danielson A., Simon T., Efantis-Potter J., Carver C.S., Duran R.E., Ironson G., Klimas N., and O'Sullivan M.J. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med 65 (2003) 427-434
9. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., and Sood A.K. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6 (2006) 240-248
10. Pantaleo G., Cohen O.J., Schacker T., Vaccarezza M., Graziosi C., Rizzardi G.P., Kahn J., Fox C.H., Schnittman S.M., Schwartz D.H., Corey L., and Fauci A.S. Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy. Nat Med 4 (1998) 341-345
11. Feldman J.G., Minkoff H., Schneider M.F., Gange S.J., Cohen M., Watts D.H., Gandhi M., Mocharnuk R.S., and Anastos K. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the Women's Interagency HIV Study. Am J Public Health 96 (2006) 1060-1065
12. Antoni M.H. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr 8 (2003) 40-51
13. Antoni M.H., Carrico A.W., Duran R.E., Spitzer S., Penedo F., Ironson G., Fletcher M.A., Klimas N., and Schneiderman N. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med 68 (2006) 143-151
14. Lechner S.C., Antoni M.H., Lydston D., LaPerriere A., Ishii M., Devieux J., Stanley H., Ironson G., Schneiderman N., Brondolo E., Tobin J.N., and Weiss S. Cognitive-behavioral interventions improve quality of life in women with AIDS. J Psychosom Res 54 (2003) 253-261
15. Folkman S., Lazarus R.S., Gruen R.J., and DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 50 (1986) 571-579
16. Minkoff H., Ahdieh L., Massad L.S., Anastos K., Watts D.H., Melnick S., Muderspach L., Burk R., and Palefsky J. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15 (2001) 2157-2164
17. Cook R.T. Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol Clin Exp Res 22 (1998) 1927-1942
18. Pereira D.B. Interventions for mothers during pregnancy and postpartum: behavioral and pharmacological approaches. In: Chesney M., and Antoni M.H. (Eds). Innovative approaches to health psychology: prevention and treatment-Lessons learned from AIDS (2002), American Psychological Association Press, Washington, DC
19. Antoni MH, Pereira DB. Cognitive behavioral stress management for HIV+ women with Human Papillomavirus infection: keeping hope alive. 1999. Ref Type: unpublished work.
20. Sarason I.G., Johnson J.H., and Siegel J.M. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol 46 (1978) 932-946
21. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 36 Suppl 1 (1987) 1S-15S
22. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., Zwickl B., and Wu A.W. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 12 (2000) 255-266
23. Preacher K.J., and Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods (2008) [in press]
24. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66 (2004) 411-421
25. Cruess S., Antoni M., Cruess D., Fletcher M.A., Ironson G., Kumar M., Lutgendorf S., Hayes A., Klimas N., and Schneiderman N. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med 62 (2000) 828-837
26. Chrousos G.P., and Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. J Am Med Assoc 267 (1992) 1244-1252
27. Cacioppo J.T., Kiecolt-Glaser J.K., Malarkey W.B., Laskowski B.F., Rozlog L.A., Poehlmann K.M., Burleson M.H., and Glaser R. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Horm Behav 42 (2002) 32-41
28. Glaser R., Kutz L.A., MacCallum R.C., and Malarkey W.B. Hormonal modulation of Epstein-Barr virus replication. Neuroendocrinology 62 (1995) 356-361
29. Bromberg-White J.L., and Meyers C. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology 306 (2003) 197-202
30. Pater M.M., Hughes G.A., Hyslop D.E., Nakshatri H., and Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature 335 (1988) 832-835
31. Bartholomew J.S., Glenville S., Sarkar S., Burt D.J., Stanley M.A., Ruiz-Cabello F., Chengang J., Garrido F., and Stern P.L. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Res 57 (1997) 937-942
32. Antoni M.H., Cruess S.E., Cruess D.G., Kumar M., Lutgendorf S., Ironson G., Dettmer E., Williams J., Klimas N., Fletcher M.A., and Schneiderman N. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann Behav Med 22 (2000) 29-37
33. Antoni M.H., Cruess D.G., Cruess S.E., Lutgendorf S., Kumar M., Ironson G., Klimas N., Fletcher M.A., and Schneiderman N. Cognitive-behavioral stress management intervention effects on anxiety, 24-hour urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol 68 (2000) 31-45
34. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., and Zack J.A. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A 98 (2001) 12695-12700
35. Cole S.W., Korin Y.D., Fahey J.L., and Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 161 (1998) 610-616
36. Cole S.W., Jamieson B.D., and Zack J.A. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J Immunol 162 (1999) 1392-1400